Market Forecast By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines), By Animal Type (Livestock, Companion), By Route of Administration (Subcutaneous, Intramuscular, Intranasal) And Competitive Landscape
Product Code: ETC312472 | Publication Date: Aug 2022 | Updated Date: Jan 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 2 | |
Egypt Animal Vaccines market currently, in 2023, has witnessed an HHI of 1858, Which has increased slightly as compared to the HHI of 1669 in 2017. The market is moving towards moderately competitive. Herfindahl index measures the competitiveness of exporting countries. The range lies from 0 to 10000, where a lower index number represents a larger number of players or exporting countries in the market while a large index number means fewer numbers of players or countries exporting in the market.
Egypt Animal Vaccines Market report thoroughly covers the market by product, by animal type, and by route of administration. The market outlook report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
The Egypt animal vaccines market is a segment poised for growth against a backdrop of increasing awareness about animal health and preventative care. As the country strengthens its agricultural sector, livestock vaccines have become integral in safeguarding the health of cattle, poultry, and other farm animals, which are crucial to the Egyptian economy.
According to 6Wresearch, the Egypt Animal Vaccines Market size is estimated to reach at a CAGR of 5.8% during the forecast period 2025-2031. The primary driver of the animal vaccines market in Egypt is the proactive governmental efforts to promote veterinary health. Government bodies and international agencies are collaborating to improve animal healthcare infrastructure, which includes widespread vaccination programs. Additionally, the rising demand for meat and dairy products encourages livestock owners to maintain their herd's health through vaccinations. Current trends in the Egyptian animal vaccines market show a spike in the adoption of technologically advanced vaccines, such as DNA vaccines, that promise stronger and more prolonged immunity. Also, there is a noticeable shift towards tailored vaccination plans crafted according to the specific needs of different animal populations, improving overall vaccine efficacy is anticipated to surge the growth of the Egypt Animal Vaccines industry in the coming years.
The Egyptian government has initiated several key programs aimed at expanding the reach and efficacy of animal vaccinations. Initiatives such as the 'National Project for the Development of Livestock and Poultry' focus on veterinary care improvements, including the establishment of regulatory frameworks for vaccine approvals and the implementation of nationwide vaccination campaigns. These efforts are supported by collaborations with entities like the Food and Agriculture Organization (FAO) to increase farmers' knowledge about animal diseases and the benefits of vaccinations.
In the competitive landscape, several multinational and local companies are active in the market. Leading entities include several leading players such as Zoetis, Merck Animal Health, and Elanco, VET Pharma and Arab Company for Pharmaceutical Products (ARABCO), play a crucial role in vaccine production and supply.
The Egypt animal vaccines market growth is anticipated to burgeon, fuelled by continued investment in animal health by the government and increased awareness among livestock owners. Advancements in vaccine technologies, coupled with improved distribution networks, are expected to reduce the impact of challenges like storage and transportation of vaccines. The addition of e-commerce platforms for veterinary products could further democratize access to animal healthcare, paving the way for significant growth in this sector.
According to Dhaval, Research Manager, 6Wresearch, Attenuated Live Vaccines are witnessing a noticeable growth within the Egypt animal vaccines market. Their ability to induce robust immune responses with fewer doses makes them highly sought after among veterinarians and livestock owners. As the market evolves, ongoing research and development in this segment are expected to further refine the safety and efficacy of these vaccines, potentially increasing their market share and influence on animal health outcomes.
The report offers a comprehensive study of the subsequent market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Egypt Animal Vaccines Market Overview |
3.1 Egypt Country Macro Economic Indicators |
3.2 Egypt Animal Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Egypt Animal Vaccines Market - Industry Life Cycle |
3.4 Egypt Animal Vaccines Market - Porter's Five Forces |
3.5 Egypt Animal Vaccines Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Egypt Animal Vaccines Market Revenues & Volume Share, By Animal Type, 2021 & 2031F |
3.7 Egypt Animal Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Egypt Animal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Egypt Animal Vaccines Market Trends |
6 Egypt Animal Vaccines Market, By Types |
6.1 Egypt Animal Vaccines Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Egypt Animal Vaccines Market Revenues & Volume, By Product, 2021 - 2031F |
6.1.3 Egypt Animal Vaccines Market Revenues & Volume, By Attenuated Live Vaccines, 2021 - 2031F |
6.1.4 Egypt Animal Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021 - 2031F |
6.1.5 Egypt Animal Vaccines Market Revenues & Volume, By Subunit Vaccines, 2021 - 2031F |
6.1.6 Egypt Animal Vaccines Market Revenues & Volume, By DNA Vaccines, 2021 - 2031F |
6.1.7 Egypt Animal Vaccines Market Revenues & Volume, By Recombinant Vaccines, 2021 - 2031F |
6.2 Egypt Animal Vaccines Market, By Animal Type |
6.2.1 Overview and Analysis |
6.2.2 Egypt Animal Vaccines Market Revenues & Volume, By Livestock, 2021 - 2031F |
6.2.3 Egypt Animal Vaccines Market Revenues & Volume, By Companion, 2021 - 2031F |
6.3 Egypt Animal Vaccines Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Egypt Animal Vaccines Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.3.3 Egypt Animal Vaccines Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.3.4 Egypt Animal Vaccines Market Revenues & Volume, By Intranasal, 2021 - 2031F |
7 Egypt Animal Vaccines Market Import-Export Trade Statistics |
7.1 Egypt Animal Vaccines Market Export to Major Countries |
7.2 Egypt Animal Vaccines Market Imports from Major Countries |
8 Egypt Animal Vaccines Market Key Performance Indicators |
9 Egypt Animal Vaccines Market - Opportunity Assessment |
9.1 Egypt Animal Vaccines Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Egypt Animal Vaccines Market Opportunity Assessment, By Animal Type, 2021 & 2031F |
9.3 Egypt Animal Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Egypt Animal Vaccines Market - Competitive Landscape |
10.1 Egypt Animal Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Egypt Animal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |